Scott Robert A

Avg. Two Year Performance

No purchase track record
62% Avg. Sale Return
27% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return14%(23%)(37%)(71%)0%
Purchase Success Rate1 of 10 of 10 of 10 of 10 of 1
Average Sale Return20%18%20%26%62%
Sale Success Rate2 of 22 of 22 of 22 of 22 of 2

Atherogenics Inc.

Drugs » Drug Manufacturers - Other

Exec VP Research & Development:

Holdings: 50.2K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Discovery Laboratories Inc.

Drugs » Biotechnology

Director:

Holdings: 2.13K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--